NO20021732L - N-Formyl Peptide Receptor Complex with a G-protein Kinase Signal Pathway Modifier and Methods for Changing Signal Transmission Following Stimulation with Pro-Inflammatory Agents - Google Patents

N-Formyl Peptide Receptor Complex with a G-protein Kinase Signal Pathway Modifier and Methods for Changing Signal Transmission Following Stimulation with Pro-Inflammatory Agents

Info

Publication number
NO20021732L
NO20021732L NO20021732A NO20021732A NO20021732L NO 20021732 L NO20021732 L NO 20021732L NO 20021732 A NO20021732 A NO 20021732A NO 20021732 A NO20021732 A NO 20021732A NO 20021732 L NO20021732 L NO 20021732L
Authority
NO
Norway
Prior art keywords
pro
methods
protein kinase
inflammatory agents
receptor complex
Prior art date
Application number
NO20021732A
Other languages
Norwegian (no)
Other versions
NO20021732D0 (en
Inventor
James A Clagett
Craig Palmer
Original Assignee
Histatek Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histatek Llc filed Critical Histatek Llc
Publication of NO20021732D0 publication Critical patent/NO20021732D0/en
Publication of NO20021732L publication Critical patent/NO20021732L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO20021732A 1999-10-15 2002-04-12 N-Formyl Peptide Receptor Complex with a G-protein Kinase Signal Pathway Modifier and Methods for Changing Signal Transmission Following Stimulation with Pro-Inflammatory Agents NO20021732L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15967799P 1999-10-15 1999-10-15
PCT/US2000/028183 WO2001029069A1 (en) 1999-10-15 2000-10-12 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent

Publications (2)

Publication Number Publication Date
NO20021732D0 NO20021732D0 (en) 2002-04-12
NO20021732L true NO20021732L (en) 2002-06-12

Family

ID=22573520

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021732A NO20021732L (en) 1999-10-15 2002-04-12 N-Formyl Peptide Receptor Complex with a G-protein Kinase Signal Pathway Modifier and Methods for Changing Signal Transmission Following Stimulation with Pro-Inflammatory Agents

Country Status (16)

Country Link
EP (1) EP1222199A4 (en)
JP (1) JP2004507441A (en)
KR (1) KR20020057972A (en)
CN (1) CN100497374C (en)
AU (1) AU8014200A (en)
BR (1) BR0014742A (en)
CA (1) CA2387559A1 (en)
CZ (1) CZ20021342A3 (en)
EA (1) EA200200451A1 (en)
HU (1) HUP0203688A2 (en)
IL (1) IL149125A0 (en)
MX (1) MXPA02003782A (en)
NO (1) NO20021732L (en)
PL (1) PL356096A1 (en)
WO (1) WO2001029069A1 (en)
ZA (1) ZA200202937B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
WO2004100978A1 (en) * 2003-05-13 2004-11-25 Medvet Science Pty. Ltd. A method of modulating cellular transmigration and agents for use therein
CN101217971B (en) 2005-07-05 2011-11-09 比奥滕普特公司 Treatment of tumors
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
WO2011036308A1 (en) * 2009-09-28 2011-03-31 Theramab Gmbh Method for preclinical testing of immunomodulatory drugs
CN115466306A (en) * 2022-01-25 2022-12-13 香港中文大学（深圳） Polypeptide targeting cell membrane surface formyl peptide receptor, pharmaceutical composition and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9815288A (en) * 1997-11-13 2001-02-13 Histatek Llc Pharmaceutical composition, processes to inhibit mast cell degranulation, to treat asthma in a patient, to treat inflammation in a patient, to inhibit the release of cytokines in a patient, to inhibit the release of histamines in a patient, to inhibit the release of leukotrienes in a patient, to reduce the adhesion, migration and aggregation of lymphocytes, eosinophils and neutrophils to a site of inflammation in a patient, to reduce the production of ige antibodies at the site of inflammation in a patient, to inhibit increased vascular permeability in inflammation site in a patient, and to treat chronic inflammation in a patient.

Also Published As

Publication number Publication date
HUP0203688A2 (en) 2003-02-28
EP1222199A4 (en) 2003-03-12
BR0014742A (en) 2002-08-27
JP2004507441A (en) 2004-03-11
EP1222199A1 (en) 2002-07-17
CA2387559A1 (en) 2001-04-26
ZA200202937B (en) 2003-09-23
CN100497374C (en) 2009-06-10
PL356096A1 (en) 2004-06-14
EA200200451A1 (en) 2002-10-31
MXPA02003782A (en) 2002-12-13
CN1633447A (en) 2005-06-29
AU8014200A (en) 2001-04-30
CZ20021342A3 (en) 2003-01-15
NO20021732D0 (en) 2002-04-12
KR20020057972A (en) 2002-07-12
WO2001029069A1 (en) 2001-04-26
IL149125A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
NO20021732L (en) N-Formyl Peptide Receptor Complex with a G-protein Kinase Signal Pathway Modifier and Methods for Changing Signal Transmission Following Stimulation with Pro-Inflammatory Agents
NO2005007I2 (en) Pemetrexed and pharmaceutically acceptable salts thereof
DK1035115T3 (en) 4-phenylpyridine derivatives and their use as NK-1 receptor antagonists
DK0808312T3 (en) Indole derivatives as a 5-HT receptor antagonist
CY2010003I1 (en) BETA-2 ADRENOREGIC RECEPTOR ANTAGONISTS
DE69831176D1 (en) KAPPA RECEPTOR OPIOID PEPTIDE
NO2006004I1 (en) Erlotinib hydrochloride and pharmaceutically acceptable salts thereof
NO2008001I1 (en) Vildagliptin and pharmaceutically acceptable salts thereof
DE69232072D1 (en) ENDOTHELINE RECEPTOR ANTAGONISTS
NO964955D0 (en) Two-way plug device for use in a wellbore
ID16742A (en) ENDOTELIN RECEPTOR ANTAGONISTS
DK0741133T3 (en) Adhesion receptor antagonists
EP0817800A4 (en) Human g-protein coupled receptors
NO995482L (en) Ergoline derivatives and their use as somatostatin receptor antagonists
NO974611D0 (en) Apparatus for use in a wellbore
HK1042099A1 (en) Human g-protein coupled receptor
IL148515A0 (en) Human g-protein coupled receptor
IL196053A0 (en) Novel human g-protein coupled receptor
EP0832122A4 (en) Human g-protein receptor hpraj70
EP1233981A4 (en) G-protein coupled receptor
GB0108983D0 (en) Molecular cloning of a 7TM receptor (AXOR34) and screening methods thereof
HU9602127D0 (en) Endotheline receptor antagonists
EP0835264A4 (en) Human g-protein receptor hcegh45
DK1237539T3 (en) Oral solution containing galanthamine and a sweetener
DE69834655D1 (en) PHARMACEUTICAL SUSPENSION WITH NEVIRAPINE HEMIHYDRATE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application